Millikan L E, Galen W K, Gewirtzman G B, Horwitz S N, Landow R K, Nesbitt L T, Roth H L, Sefton J, Day R M
Tulane University Medical Center, New Orleans, LA.
J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):52-6. doi: 10.1016/s0190-9622(88)70008-0.
Data from 104 subjects with tinea cruris or tinea corporis were evaluated in this double-blind, randomized study. The subjects applied naftifine cream 1% or econazole nitrate cream 1% to affected areas twice daily for 4 weeks. After 1 week of treatment naftifine had an overall cure rate of 19% compared with 4% for econazole (p = 0.03). A difference in favor of naftifine, although not statistically significant after the first week, persisted throughout treatment. Two weeks after the end of treatment both medications had overall cure rates of approximately 80%. Three percent of the naftifine-treated subjects had side effects compared with 13% of the econazole-treated subjects. In two subjects using econazole, the side effects were severe enough to warrant discontinuation of treatment.
在这项双盲、随机研究中,对104例患有股癣或体癣的受试者的数据进行了评估。受试者每天两次将1%萘替芬乳膏或1%硝酸益康唑乳膏涂抹于患处,持续4周。治疗1周后,萘替芬的总体治愈率为19%,而益康唑为4%(p = 0.03)。尽管在第一周后萘替芬的优势差异无统计学意义,但在整个治疗过程中一直存在。治疗结束两周后,两种药物的总体治愈率均约为80%。接受萘替芬治疗的受试者中有3%出现副作用,而接受益康唑治疗的受试者中有13%出现副作用。在两名使用益康唑的受试者中,副作用严重到足以导致停药。